Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Decai Yu

Showing results (81-90 of 99) with videos related to

Pageof 10
Sort By:
Oncogene|October 13, 2019
VersicanV1 promotes proliferation and metastasis of hepatocellular carcinoma through the activation of EGFR-PI3K-AKT pathwayGuangyan Zhangyuan, Fei Wang, Haitian Zhang, et al.
Oncogene|November 9, 2019
Correction: VersicanV1 promotes proliferation and metastasis of hepatocellular carcinoma through the activation of EGFR-PI3K-AKT pathwayGuangyan Zhangyuan, Fei Wang, Haitian Zhang, et al.
Gut|June 3, 2019
APOBEC3B interaction with PRC2 modulates microenvironment to promote HCC progressionDuowei Wang, Xianjing Li, Jiani Li, et al.
Cell Death and Differentiation|July 7, 2023
Oxoglutarate dehydrogenase-like inhibits the progression of hepatocellular carcinoma by inducing DNA damage through non-canonical functionXiang Jiang, Jin Peng, Yuanyuan Xie, et al.
Cancer Research|July 27, 2022
GOT2 Silencing Promotes Reprogramming of Glutamine Metabolism and Sensitizes Hepatocellular Carcinoma to Glutaminase InhibitorsYunzheng Li, Binghua Li, Yanchao Xu, et al.
Cellular Oncology (Dordrecht, Netherlands)|July 14, 2025
S100A9 promotes resistance to anti-PD-1 immunotherapy in hepatocellular carcinoma by degrading PARP1 and activating the STAT3/PD-L1 pathwayXianwei Zhou, Chu Qiao, Xuehui Chu, et al.
BMC Cancer|November 10, 2023
Kidney-type glutaminase is a biomarker for the diagnosis and prognosis of hepatocellular carcinoma: a prospective studyLaizhu Zhang, Ke Su, Qi Liu, et al.
Cell Death & Disease|March 10, 2026
β-catenin mutation reprograms ketone body metabolism to drive hepatocellular carcinoma metastasis and resistance to ketogenic therapy via transcriptional activation of OXCT1Huan Li, Liyuan Qian, Yifan Ji, et al.
The Journal of Pathology|July 5, 2018
Geranylgeranyl diphosphate synthase (GGPPS) regulates non-alcoholic fatty liver disease (NAFLD)-fibrosis progression by determining hepatic glucose/fatty acid preference under high-fat diet conditionsJia Liu, Shan Jiang, Yue Zhao, et al.
Langmuir : the ACS Journal of Surfaces and Colloids|August 26, 2024
Impact of Degree of Ethoxylation on Sodium Lauryl Ether Sulfate Surfactant Adsorption onto Silicone-in-Water Emulsion DropletsDaniel S Miller, Meng Jing, Decai Yu, et al.
Pageof 10

Showing results (81-90 of 99) with videos related to

Sort By:
Pageof 10
Oncogene|October 13, 2019
VersicanV1 promotes proliferation and metastasis of hepatocellular carcinoma through the activation of EGFR-PI3K-AKT pathwayGuangyan Zhangyuan, Fei Wang, Haitian Zhang, et al.
Oncogene|November 9, 2019
Correction: VersicanV1 promotes proliferation and metastasis of hepatocellular carcinoma through the activation of EGFR-PI3K-AKT pathwayGuangyan Zhangyuan, Fei Wang, Haitian Zhang, et al.
Gut|June 3, 2019
APOBEC3B interaction with PRC2 modulates microenvironment to promote HCC progressionDuowei Wang, Xianjing Li, Jiani Li, et al.
Cell Death and Differentiation|July 7, 2023
Oxoglutarate dehydrogenase-like inhibits the progression of hepatocellular carcinoma by inducing DNA damage through non-canonical functionXiang Jiang, Jin Peng, Yuanyuan Xie, et al.
Cancer Research|July 27, 2022
GOT2 Silencing Promotes Reprogramming of Glutamine Metabolism and Sensitizes Hepatocellular Carcinoma to Glutaminase InhibitorsYunzheng Li, Binghua Li, Yanchao Xu, et al.
Cellular Oncology (Dordrecht, Netherlands)|July 14, 2025
S100A9 promotes resistance to anti-PD-1 immunotherapy in hepatocellular carcinoma by degrading PARP1 and activating the STAT3/PD-L1 pathwayXianwei Zhou, Chu Qiao, Xuehui Chu, et al.
BMC Cancer|November 10, 2023
Kidney-type glutaminase is a biomarker for the diagnosis and prognosis of hepatocellular carcinoma: a prospective studyLaizhu Zhang, Ke Su, Qi Liu, et al.
Cell Death & Disease|March 10, 2026
β-catenin mutation reprograms ketone body metabolism to drive hepatocellular carcinoma metastasis and resistance to ketogenic therapy via transcriptional activation of OXCT1Huan Li, Liyuan Qian, Yifan Ji, et al.
The Journal of Pathology|July 5, 2018
Geranylgeranyl diphosphate synthase (GGPPS) regulates non-alcoholic fatty liver disease (NAFLD)-fibrosis progression by determining hepatic glucose/fatty acid preference under high-fat diet conditionsJia Liu, Shan Jiang, Yue Zhao, et al.
Langmuir : the ACS Journal of Surfaces and Colloids|August 26, 2024
Impact of Degree of Ethoxylation on Sodium Lauryl Ether Sulfate Surfactant Adsorption onto Silicone-in-Water Emulsion DropletsDaniel S Miller, Meng Jing, Decai Yu, et al.
Pageof 10